INS and Obesity: Many potential mechanisms have been identified about the role of obesity and diabetes (or hyperglycemia) in the development of endometrial cancer (27), including adipocyte-derived estrogen signaling, insulin resistance, and synergistic interaction of estradiol and insulin signaling, while studies on the link between hypertension or lipid disorders and endometrial cancer were relatively limited.